EUVIMEDEUVIMED entdecken
Crossref

Eight-Week Randomized, Double-Blind, Placebo-Controlled 2-Site Trial Assessing the Efficacy and Safety of Mixed Amphetamine Salt as an Adjunctive Therapy for Bipolar Depression

Mark A. Frye, Jorge A. Sanchez-Ruiz, Nicolas Nunez, Karin Lindstrom, Vanessa K. Pazdernik, Nicole Mori, Balwinder Singh, Marin Veldic, Aysegul Ozerdem, Georgi Georgiev, Dina N. Ali, Ashok Seshadri und 7 weitere

The Journal of Clinical Psychiatry · 16.11.2026 · 87 (4)

DOI: 10.4088/jcp.26m16446 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Psychiatry, online erschienen am 16.11.2026. Verfasst von Mark A. Frye und 18 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study examined the efficacy and safety of adjunctive mixed d -amphetamine/ l -amphetamine salt (MAS; Mydayis) in adults with DSM-IV-TR –confirmed bipolar I or II depression.

Methods

In this 8-week, randomized, placebo-controlled 2-site study of adjunctive MAS, the primary outcome was baseline-to-end point change in the Montgomery-Asberg Depression Rating Scale (MADRS). Secondary outcomes included, in part, treatment response and remission (≥50% MADRS reduction, MADRS

Zitieren

APA

Frye, M. A., Sanchez-Ruiz, J. A., Nunez, N., Lindstrom, K., Pazdernik, V. K., Mori, N., Singh, B., Veldic, M., Ozerdem, A., Georgiev, G., Ali, D. N., Seshadri, A., Baruth, J., Moore, K. M., Betcher, H., Mather-Brooks, N., Yang, P., Biernacka, J. M., & McElroy, S. L. (2026). Eight-Week Randomized, Double-Blind, Placebo-Controlled 2-Site Trial Assessing the Efficacy and Safety of Mixed Amphetamine Salt as an Adjunctive Therapy for Bipolar Depression. The Journal of Clinical Psychiatry, 87(4). https://doi.org/10.4088/jcp.26m16446

Vancouver

Frye MA, Sanchez-Ruiz JA, Nunez N, Lindstrom K, Pazdernik VK, Mori N, et al. Eight-Week Randomized, Double-Blind, Placebo-Controlled 2-Site Trial Assessing the Efficacy and Safety of Mixed Amphetamine Salt as an Adjunctive Therapy for Bipolar Depression. The Journal of Clinical Psychiatry. 2026;87(4). doi:10.4088/jcp.26m16446

BibTeX
@article{Frye2026,
  author = {Frye, Mark A. and Sanchez-Ruiz, Jorge A. and Nunez, Nicolas and Lindstrom, Karin and Pazdernik, Vanessa K. and Mori, Nicole and Singh, Balwinder and Veldic, Marin and Ozerdem, Aysegul and Georgiev, Georgi and Ali, Dina N. and Seshadri, Ashok and Baruth, Joshua and Moore, Katherine M. and Betcher, Hannah and Mather-Brooks, Nicky and Yang, Padao and Biernacka, Joanna M. and McElroy, Susan L.},
  title = {Eight-Week Randomized, Double-Blind, Placebo-Controlled 2-Site Trial Assessing the Efficacy and Safety of Mixed Amphetamine Salt as an Adjunctive Therapy for Bipolar Depression},
  journal = {The Journal of Clinical Psychiatry},
  year = {2026},
  volume = {87},
  number = {4},
  doi = {10.4088/jcp.26m16446}
}
Kostenlos starten →